11596311

Omni MedSci asserts eight patents, including US 12,588,820, against Samsung. The '820 is asserted at least in claims 9 and 10 against Samsung's Galaxy XR headset based on direct time-of-flight sensing. Relief sought includes declaratory judgment of infringement, damages, permanent injunction, and attorney's fees.

Omni MedSci infringement action against Apple Inc. The narrative states it asserted the '533, '040, '286, and '698 patents and proceeded through Omni MedSci, Inc. v. Apple Inc. (Fed. Cir. 2021) on standing/assignment before concluding; the '311 patent is not confirmed as asserted.

Omni MedSci infringement action against Oura Health Oy in the Eastern District of Texas, filed April 10, 2026. It is the lead consolidated case for the 2026 E.D. Tex. filings; pending. The narrative does not list asserted patents for this case.

Omni MedSci infringement action against Fossil Group, Inc. et al. in the Eastern District of Texas, filed June 12, 2026. Pending; the narrative does not list asserted patents for this case.

Omni MedSci infringement action against OnePlus Technology (Shenzhen) Co., Ltd. in the Eastern District of Texas, filed June 12, 2026. Consolidated for pretrial issues under 2:26-cv-00289 per a June 17, 2026 order; pending. The narrative does not list asserted patents for this case.